Clinical trial
Effect of Metreleptin Therapy in the Treatment of Severe Insulin Resistance
NCT00085982 · National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), NIH · Active, not recruiting
Key facts
| NCT number | NCT00085982 |
|---|---|
| Title | Effect of Metreleptin Therapy in the Treatment of Severe Insulin Resistance |
| Official title | Phase II Trial of Effect of Metreleptin Therapy in Severe Insulin Resistance |
| Lead sponsor | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), NIH |
| Status | Active, not recruiting |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Severe Insulin Resistance |
| Intervention type | Drug |
| Interventions | Metreleptin |
| Enrollment | 11 |
| Start date | Aug 21, 2003 |
| Primary completion | Oct 23, 2019 |
| Completion | Jan 1, 2030 |
| First posted | Jun 21, 2004 |
| Last update posted | Jan 30, 2025 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: